Status:
NOT_YET_RECRUITING
Measuring the Density of Iodine in Lipiodol Depositions: Detecting an Invisible Residual Tumor After Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma
Lead Sponsor:
Pak Emirates Military Hospital
Conditions:
HCC - Hepatocellular Carcinoma
Eligibility:
All Genders
16-60 years
Phase:
NA
Brief Summary
ABSTRACT Objective: To detect presence of a residual tumor in patients of hepatocellular carcinoma (HCC) treated with Lipiodol based conventional trans arterial chemoembolization (cTACE) using density...
Eligibility Criteria
Inclusion
- Clinical diagnosis of HCC disease
- Must be able to swallow tablets
Exclusion
- Insulin dependent diabetes
- Thyroid disease
Key Trial Info
Start Date :
October 12 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 13 2025
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT06602986
Start Date
October 12 2024
End Date
July 13 2025
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PakEmiratesMH
Rawalpindi, Punjab Province, Pakistan, 55050